These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6967756)

  • 61. Cell-mediated cytotoxicity against syngeneic tumors.
    Sinclair NR; McFarlane DL; Low JM
    Cell Immunol; 1981 Apr; 59(2):330-44. PubMed ID: 6793241
    [No Abstract]   [Full Text] [Related]  

  • 62. [Immunomodulating effect of levamisole on cell-mediated immunity (author's transl)].
    Miwa H; Orita K
    Nihon Gan Chiryo Gakkai Shi; 1981 Oct; 16(6):1231-8. PubMed ID: 7037998
    [No Abstract]   [Full Text] [Related]  

  • 63. Influence of polyunsaturated fatty acids on survival of skin allografts and tumor incidence in mice.
    Mertin J; Hunt R
    Proc Natl Acad Sci U S A; 1976 Mar; 73(3):928-31. PubMed ID: 768987
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hyperthermia and formaldehyde can dissociate the binding and killing activities of cytolytic T lymphocytes.
    Berke G; Fishelson Z; Schick B
    Transplant Proc; 1979 Mar; 11(1):804-6. PubMed ID: 313104
    [No Abstract]   [Full Text] [Related]  

  • 65. Human tumor cloning: drug sensitivity testing clinical correlations.
    Alberts DS; Salmon SE; Moon TE
    Prog Clin Cancer; 1982; 8():147-79. PubMed ID: 6760247
    [No Abstract]   [Full Text] [Related]  

  • 66. Investigation into the immunological effects of miltefosine, a new anticancer agent under development.
    Hilgard P; Kampherm E; Nolan L; Pohl J; Reissmann T
    J Cancer Res Clin Oncol; 1991; 117(5):403-8. PubMed ID: 1890137
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Antitumor immunoadjuvant activity and the immunoregulatory mechanisms of yeasts and their components].
    Marconi P; Bistoni F
    Ann Ist Super Sanita; 1982; 18(3):501-8. PubMed ID: 6765083
    [No Abstract]   [Full Text] [Related]  

  • 68. [Leukocyte facilitation in experimental tumors].
    Pugliese A
    G Batteriol Virol Immunol; 1976; 69(1-6):139-48. PubMed ID: 1088266
    [No Abstract]   [Full Text] [Related]  

  • 69. Tumor immunity.
    Siegel BV; Cohen S
    Fed Proc; 1978 Jul; 37(9):2212-4. PubMed ID: 658461
    [No Abstract]   [Full Text] [Related]  

  • 70. Macrophage regulation of the T-cell allogeneic response during tumor growth.
    Elgert KD; Connolly KM
    Cell Immunol; 1978 Jan; 35(1):1-14. PubMed ID: 145897
    [No Abstract]   [Full Text] [Related]  

  • 71. Foot pad reaction against syngeneic tumor cells.
    Nakamura J; Hisano G; Tsubura E
    Tokushima J Exp Med; 1984 Jun; 31(1-2):21-8. PubMed ID: 6528341
    [No Abstract]   [Full Text] [Related]  

  • 72. Selective effects of Adriamycin on murine host defense systems.
    Ehrke MJ; Cohen SA; Mihich E
    Immunol Rev; 1982; 65():55-78. PubMed ID: 6811413
    [No Abstract]   [Full Text] [Related]  

  • 73. [Changes in various indicators of immunity in inflammatory processes].
    Tchórzewski H
    Acta Physiol Pol; 1982; 33 Suppl 24():1-18. PubMed ID: 6756035
    [No Abstract]   [Full Text] [Related]  

  • 74. Differential effects of ouabain on human cell-mediated cytotoxicity. I. Inhibition of mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity against chicken red cell targets.
    Lawrence EC; Muchmore AV; Dooley NJ; Blaese RM
    Cell Immunol; 1979 Aug; 46(1):100-9. PubMed ID: 314844
    [No Abstract]   [Full Text] [Related]  

  • 75. New immunosuppressive activity of dykellic acid.
    Han SB; Lee HJ; Kho YH; Jeon YJ; Lee SH; Kim HC; Kim HM
    J Antibiot (Tokyo); 2001 Oct; 54(10):840-3. PubMed ID: 11776441
    [No Abstract]   [Full Text] [Related]  

  • 76. [Health status of workers in contact with dimethyl sulfate (clinico-hygienic, immunological and cytogenetic research)].
    Molodkina NN; Fomenko VN; Obbarius ID; Katosova LD; Snegova GV
    Gig Tr Prof Zabol; 1985 Mar; (3):32-5. PubMed ID: 3874119
    [No Abstract]   [Full Text] [Related]  

  • 77. [Activated T-lymphocytes--a mode of physiological tumor defence].
    Röllinghoff M; Wagner H
    Verh Dtsch Ges Inn Med; 1974; 80():1584-6. PubMed ID: 4548989
    [No Abstract]   [Full Text] [Related]  

  • 78. Effects of central administration of morphine on immune status in Lewis and Wistar rats.
    Hoffman KE; Maslonek KA; Dykstra LA; Lysle DT
    Adv Exp Med Biol; 1995; 373():155-9. PubMed ID: 7668146
    [No Abstract]   [Full Text] [Related]  

  • 79. [Thymus hormones in the immunotherapy of malignant neoplasms (a review of the literature)].
    Nikol'skiĭ IS
    Vrach Delo; 1988 Aug; (8):77-82. PubMed ID: 3061171
    [No Abstract]   [Full Text] [Related]  

  • 80. [Changes in the sensitivity of EMT6/VJAC cells to bleomycin and hyperthermia due to the growth phase of the cell culture].
    Mircheva I; Smith P; Bleehen NM
    Eksp Med Morfol; 1986; 25(4):11-6. PubMed ID: 2434301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.